Could AEON Biopharma Inc (AMEX: AEON) Deliver Exceptional Returns?

In the last trading session, 2.18 million shares of the AEON Biopharma Inc (AMEX:AEON) were traded, and its beta was 0.26. Most recently the company’s share price was $0.61, and it changed around -$0.14 or -18.67% from the last close, which brings the market valuation of the company to $0.68M. AEON currently trades at a discount to its 52-week high of $1236.24, offering almost -202562.3% off that amount. The share price’s 52-week low was $0.67, which indicates that the current value has fallen by an impressive -9.84% since then.

AEON Biopharma Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended AEON as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. AEON Biopharma Inc is expected to report earnings per share of 0 for the current quarter.

AEON Biopharma Inc (AMEX:AEON) trade information

Instantly AEON has showed a red trend with a performance of -18.67% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.9208 on recent trading dayincreased the stock’s daily price by 93.16%. The company’s shares are currently down -98.43% year-to-date, but still down -92.96% over the last five days. On the other hand, AEON Biopharma Inc (AMEX:AEON) is -92.94% down in the 30-day period.